The site selection process is complicated by outdated data, limited operational insight, and overreliance on reputation. Discover some practical ways to evaluate site feasibility for your next trial.
- Heading For An M&A? Understand The Risks And Mitigation Strategies For Clinical Trial Agreements
- Sites Are 3X Likely To Die In The First Year Than New Businesses
- Sponsors Collect Too Much "Non-Essential" Data, Say Tufts And TransCelerate
- Two Former FDA Chiefs, Two Very Different Warnings
- Global Implications Of Zero Tariffs On Indian Pharma Exports To China
- Participant Recruitment In LMIC Clinical Trials
- Behavior Modeling Can Help Sponsors Better Understand Sites And Patients
GUEST COLUMNISTS
-
![Human mind, experience diversity, personality characteristics-GettyImages-2203518410]( "Behavior Modeling Can Help Sponsors Better Understand Sites And Patients")
Behavior Modeling Can Help Sponsors Better Understand Sites And PatientsLearn how behavioral modeling can identify patients at risk of dropout and sites that may need additional support, so you can build a more resilient research network.
-
![China and united states flag-GettyImages-1089423344]( "How The U.S. Can Beat China In Biotech")
How The U.S. Can Beat China In BiotechLumen Bioscience's Brian Finrow breaks down China's biotech playbook and explores ways the U.S. can adapt it for its own continued success.
-
![Businesswoman walking in crowd-GettyImages-2208884463]( "How AI Is Transforming Patient Stratification")
How AI Is Transforming Patient StratificationDiscover how AI tools can help stratify or group patients into subtypes that respond differently to treatment.
-
![colorful arrows pointing up-GettyImages-2152056193]( "The Rise Of Specialist CROs In Clinical Outsourcing")
The Rise Of Specialist CROs In Clinical OutsourcingUnderstand the trends behind the growing specialist CRO sector.
-
![Online documentation database, AI, artificial intelligence, dms, GettyImages-2078225287]( "How AI Is Rewriting The Future Of TMF And Clinical Quality")
How AI Is Rewriting The Future Of TMF And Clinical QualityDiscover how AI is transforming the TMF from a reactive repository into a proactive, intelligent co-pilot for clinical trials.
-
![beroe_raredisease3-gettyimages-1629549075]( "Trends In Rare Disease Trials: Recommendations")
Trends In Rare Disease Trials: RecommendationsIn the third article of this series, analyst reveal their top 6 recommendations for designing selection criteria and selecting solution options to optimize rare disease research outcomes.
-
![Senior man at clinic reception desk-GettyImages-2174582061]( "The Hidden Power Of Specialized Community Research Sites In Accelerating Clinical Trials")
The Hidden Power Of Specialized Community Research Sites In Accelerating Clinical TrialsTyler Research Institute founder G. Aaron DuVall explores how community sites can offer access to diverse patient populations and build processes tailored for chronic disease care to accelerate timelines and improve outcomes.
-
![Career Path-GettyImages-2239749438]( "Regulatory Pathways — With Real-Life Examples — For Successful CGT Clinical Trials")
Regulatory Pathways — With Real-Life Examples — For Successful CGT Clinical TrialsDiscover the most effective regulatory pathways used to support CGT development, including two real-life examples.
CLINICAL TRIAL WHITE PAPERS
-
![GettyImages-681726866 patient, payment, reimbursement]( "A Guide To Patient Reimbursements And Payments")
A Guide To Patient Reimbursements And PaymentsDelayed or inadequate payments can harm patient retention and site efficiency. Learn how sponsors can mitigate financial toxicity, streamline reimbursement, and ensure a positive experience for all involved.
-
Accelerate Drug Development With Master Protocols5/15/2025
Through careful planning, aligned incentives, and an open, adaptive mindset, master protocols become powerful engines for accelerating therapies to market—particularly in high-need therapeutic areas.
-
Driving Customer Profitability With Enterprise Platform, Pricing2/29/2024
Explore how the solutions and approaches offered by CDS can help different research stakeholders conduct more cost-efficient clinical trials in the industry's pharmaceutical, biotech, and device sectors.
-
Navigating The Global Epilepsy Clinical Trial Terrain In 20246/3/2024
Explore the forefront of epilepsy research with Novotech CRO's comprehensive analysis, unveiling innovative therapies, clinical trials, and future trends shaping epilepsy care.
-
The Evolution Of SDV, SDR, And RBQM In Clinical Trial Data Quality11/18/2024
Explore the inefficiency of complete SDV and how the adoption of technologies like centralized monitoring, remote SDR, and targeted SDV can enhance data integrity and cost-effectiveness.
-
The Annual Clinical Trials Roundup11/20/2023
Delve into in-depth analyses of key diseases, players, and geographies influencing the pharmaceutical industry through an overview of Phase 1–3 clinical trials initiated in 2022 across all therapeutic areas.
CLINICAL TRIAL APP NOTES & CASE STUDIES
-
Use Case: A Patient-Centric Approach To Site Selection1/27/2025
Discover how Citeline’s robust datasets, combined with real-world data, inform intelligent site and investigator selection for a rare, autoimmune disease.
-
RWD's Significance In The Largest FDA-Funded IOL Study Of Pediatric Patients5/28/2025
With FDA grant support, the American Academy of Ophthalmology and Verana Health conducted the largest real-world study to date on intraocular lens (IOL) use in pediatric cataract patients.
-
Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study1/6/2025
Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.
-
Overcoming Participant Compliance Challenges In A Medical Device Study9/9/2024
Uncover how Catalyst Clinical Research enhanced participant compliance and streamlined scheduling for a TENS device study using the TrialKit platform, with crucial support from CDS.
-
How Clinical Research Skyrocketed Revenue For A Private GI Practice8/16/2024
Uncover how this small gastrointestinal (GI) practice successfully integrated clinical research into its operations and made valuable contributions to the field.
-
Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial1/16/2024
Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
NEWSLETTER ARCHIVE
- 11.14.25 -- Why CRA Proficiency Needs A Boost From Better Assessment And Training
- 11.14.25 -- Less Workload, More Patient Time: Elevating The Site Voice
- 11.13.25 -- The Rise Of Specialist CROs In Clinical Outsourcing
- 11.13.25 -- From Chaos To Control: Modernizing Data And Mastering Clinical Trials
- 11.12.25 -- Ask An Expert Before Shredding Your Mobile Device CAPEX
RECRUITMENT AND DIVERSITY
This section includes some helpful resources regarding patient recruitment and diversity in clinical trials, including this link to the FDA's guidance on diversity action plans.
-
![metaverse technology-GettyImages-1372364665]( "Non-Invasive Brain-Computer Interface Trial Balances Regulatory Requirements With Patient Needs")
Cognixion CTO Chris Ullrich introduces the Axon-R Nucleus bio-sensing hub and discusses its feasibility trial, highlighting the importance of patient input, caregiver quality of life, and regulatory support.
-
![community nurse with three teens-GettyImages-1442937688]( "Participant Recruitment In LMIC Clinical Trials")
Due to the high burden of infectious diseases in low- and middle-income countries (LMICs), there is greater urgency for vaccine trials. Participant recruitment entails significant work with communities.
-
![Human mind, experience diversity, personality characteristics-GettyImages-2203518410]( "Behavior Modeling Can Help Sponsors Better Understand Sites And Patients")
Learn how behavioral modeling can identify patients at risk of dropout and sites that may need additional support, so you can build a more resilient research network.
FOCUS ON PATIENTS
-
![metaverse technology-GettyImages-1372364665]( "Non-Invasive Brain-Computer Interface Trial Balances Regulatory Requirements With Patient Needs")
Cognixion CTO Chris Ullrich introduces the Axon-R Nucleus bio-sensing hub and discusses its feasibility trial, highlighting the importance of patient input, caregiver quality of life, and regulatory support.
-
![Human mind, experience diversity, personality characteristics-GettyImages-2203518410]( "Behavior Modeling Can Help Sponsors Better Understand Sites And Patients")
Learn how behavioral modeling can identify patients at risk of dropout and sites that may need additional support, so you can build a more resilient research network.
-
![sunlit brain puzzle-GettyImages-2187021354]( "How Redefining The Diagnostic Odyssey Can Lead To Better Patient Outcomes")
Patient advocate Wendy Cogan calls for improved diagnostic pathways as a means to better clinical trial recruitment and design while telling the journey of her late husband's journey to a corticobasal degeneration(CBD)-frontal behavioral-spatial syndrome (FBS) diagnosis.
